Dysmenorrhea and dysfunctional uterine bleeding

Apgar BS, B S Apgar
Primary care · 1997 · vol. 24(1) , pp. 161–78 · PMID:9016734 · W2414056650
Review OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Dysfunctional uterine bleeding is diagnosed after excluding endometrial cancer and treated with estrogen, oral contraceptives, or progestins, while dysmenorrhea and menorrhagia are managed with antiprostaglandins, hormonal agents, or surgical interventions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Dysfunctional uterine bleeding is a diagnosis of exclusion. Endometrial cancer and endometrial precursor lesions must be excluded before a diagnosis of anovulatory bleeding is made. Treatment consists of intravenous estrogen therapy, oral contraceptive pills, and progestational agents. Menorrhagia is excessive menstrual bleeding treated with antiprostaglandins, levonorgestrel-releasing intrauterine contraceptive devices, endometrial ablation, and danazol. Dysmenorrhea results from the release of prostaglandin 2alpha and is treated with antiprostaglandin agents such as nonsteroidal anti-inflammatory drugs.

My notes (saved in your browser only)

Condition tags

dysmenorrhea

MeSH descriptors

Dysmenorrhea Uterine Hemorrhage Adult Biopsy Diagnosis, Differential Dysmenorrhea Dysmenorrhea Endometrial Hyperplasia Endometrial Hyperplasia Endometrial Neoplasms Endometrial Neoplasms Endometrium Endometrium Estrogens Estrogens Estrogens Female Humans Hysteroscopy Menorrhagia

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:02.201502+00:00
License: CC0 · commercial use OK